Global autoimmune disease treatment market is set to witness a substantial CAGR of 7.60% in the forecasted period of 2019-2026. This rise in the market can be attributed due to enhancement in autoimmune diagnosis and technology advancement in the industry.
Global autoimmune disease treatment market is set to witness a substantial CAGR of 7.60% in the forecasted period of 2019-2026. This rise in the market can be attributed due to enhancement in autoimmune diagnosis and technology advancement in the industry.
The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period. The autoimmune disease therapeutics market is anticipated to experience significant market growth during the forecast period due to early diagnosis of the disease, the latest launch of advanced therapy, and increased incidence of autoimmune disease. The market is witnessing a strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, olokizumab, apremilast, abatacept, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other hand, higher costs associated with sophisticated therapy are anticipated to hamper the market growth. Full Report: https://www.kbvresearch.com/autoimmune-disease-therapeutics-market/
According to a new market research report, ‘Global Autoimmune Treatment Market (2009–2014)’, published by MarketsandMarkets, the global autoimmune treatment market is expected to be worth US$68.81 billion by 2014, with an estimated CAGR of 12.7% from 2009 to 2014. The North American market is expected to account for nearly 42% of the total revenues.
Graves’ disease is an autoimmune disorder of the thyroid gland that causes hyperthyroidism, overproduction of the thyroid hormones. Immune system attacks the thyroid gland and causes inflammation which results in overactive thyroid and excessive production of thyroid hormones. A person with Graves’s diseases experiences symptoms like enlarged thyroid, anxiety, hand tremor, heat sensitivity, weight loss, puffy eyes among others.
Global Graves disease treatment market is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment and increase in awareness about the complications associated with thyroid disorders and rising investment in the research & development of treatments for Hashimoto’s thyroiditis is expected to drive the market.
Innovative treatments are being developed by researchers, who are mainly focusing on reducing inflammation by using immunosuppressive therapies. Although these treatments promise remission in patients, risk of complications or relapse from long-lasting therapy prevail as key concerns. Significant improvements in the healthcare industry will stimulate in dealing with the rising instances regarding rare inflammatory diseases.
Global Autoimmune Treatment Market is expected to reach USD 50.92 billion by 2025, from USD 37.79 billion in 2017 growing at a CAGR of 3.8% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get more details @ http://bit.ly/2eg7VII Some of the players in global autoimmune disease diagnostics market are Abbott Laboratories, Siemens Healthcare, Beckman Coulter Inc. and Quest Diagnostics.
Get more details @ http://bit.ly/2eg7VII Global autoimmune disease diagnostics market share is undergoing rapid consolidation, and is marked by the presence of extensive mergers and acquisitions. Major players compete on the basis of price, and introduction of new technologically improved diagnostic kits in the market.
Big Market Research “Autoimmune Diseases Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/autoimmune-diseases-in-the-us-2015-2019-market Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents.
GBI Research has released its latest research, “Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential”. The report provides insights into the up-and-coming trends of a portion of the acquired orphan blood disorder pharmaceutical market by examining Idiopathic Thrombocytopenic Purpura (ITP), Myelodysplastic Syndrome (MDS), Myelofibrosis (MF), Paroxysmal Nocturnal Hemoglobinuria (PNH) and Polycythemia Vera (PV) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. View full report with TOC: http://www.reportsandintelligence.com/acquired-orphan-blood-diseases-therapeutics-to-2019-search-for-disease-modifying-drugs-central-to-unlocking-premium-pricing-potential-market
Big Market Research, Global Liver Diseases Therapeutics Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Liver diseases are one of the most prevalent diseases in the world. The commercialization of variety of liver therapeutics drugs has made the treatment of these diseases possible. The report provides an in-depth intelligence about current market trends of liver diseases therapeutics market. The objective of this report is to study the demand these therapeutics in the market and to assess its growth.
The report on Biosimilar Monoclonal Antibodies by Infinium Global Research analyzes the the Biosimilar Monoclonal Antibodies Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biosimilar Monoclonal Antibodies Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global markets of Biosimilar Monoclonal Antibodies.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Big Market Research “Global Inflammatory Bowel Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. Visit for more info @ http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss.
How do we know a treatment works. How do we know a ... Yes - teratogenic. Not demonstrated. Established. Methotrexate. Yes. Established. Established 55 ...
The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors. Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market
The global “idiopathic inflammatory myopathy treatment market size” is projected to reach USD 930.6 million by 2026, thereby exhibiting a CAGR of 4.6% during the forecast period.
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. Prior to 1998, treatment options were limited to small-molecule disease-modifying therapies, such as Methotrexate (MTX), sulfasalazine and anti-malarials. However, while MTX is efficacious in controlling RA symptoms in a large percentage of patients, approximately 33% are unresponsive to these first-line drugs. Read more details at: http://www.bigmarketresearch.com/rheumatoid-arthritis-to-2020-a-crowded-characterized-by-modest-growth-market
The global thyroid gland disorder market is estimated to reach $2,771 million at a CAGR of 3.8% from 2018 to 2025. North America was the highest contributor to the thyroid gland disorder treatment market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. Prior to 1998, treatment options were limited to small-molecule disease-modifying therapies, such as Methotrexate (MTX), sulfasalazine and anti-malarials.
Adroit Market Research, recently published a detailed market research study focused on the “Biosimilars Market” across the global, regional and country level.
Big Market Research, Medicago S.P.A Product Pipeline Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Medicago Inc. - Product Pipeline Review - 2014’, provides an overview of the Medicago Inc.’s pharmaceutical research and development focus.
The report on Biosimilar Market by product (human growth hormones, monoclonal antibodies, insulin, peptides, erythropoietin and others), application, (oncology, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biosimilar Market is projected to grow at a CAGR between 25.0% to 26.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Immunotherapy Drugs Market by product (monoclonal antibodies, checkpoint inhibitors, vaccines, inferon’s and others), by disease condition (cancer, infectious disease, autoimmune disease, and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Immunotherapy Drugs Market is projected to grow at a CAGR between 13.5 % to 14.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Biological Drugs Market by Infinium Global Research analyzes the Biological Drugs Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biological Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Biological Drugs Market.
Global Biosimilars market is estimated to reach $46.0 Billion by 2025; growing at a CAGR of 33% from 2017 to 2025. Biosimilars are the biotechnological product that is proved to be comparable to an already approved reference product in quality, non‐clinical and clinical evaluation.
Big Market Research, iBio Inc product pipeline market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘iBio, Inc. - Product Pipeline Review - 2014’, provides an overview of the iBio, Inc.’s pharmaceutical research and development focus.
This report provides the current incident population for AIHA across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort.
Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.
Chronic Pancreatitis Pain Market shows the methods for the diagnosis of chronic pancreatitis that includes Trans-abdominal ultrasound, pancreatic function test, pancreas exocrine function test, Computerized Tomography (CT) scans, Magnetic Resonance Cholangiopancreatography (MRCP), endoscopic ultrasound, genetic testing and Endoscopic Retrograde Cholangiopancreatography (ERCP). This major innovation is helping a lot in finding out pancreas problems. Mostly CT scan and trans-abdominal ultrasound is the major used diagnosis test for pancreatitis treatment.
New Report on "Worldwide Rheumatoid Arthritis Market" added to marketresearchfuture.com database. The Industry Report Provide analysis and assessment of the present profitability.
The report on Biological Drugs Market by roduct Type (therapeutic protein -levemir, neulasta, eylea, novolog, enbrel, avonex, neupogen, humalog, victoza, lantus, epogen, aranesp; monoclonal antibody - avastin, humira, remicade; vaccine - gardasil, prenvar 13, fluzone) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biological Drugs Market is projected to grow at a CAGR between 10.0% to 10.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The Contribution of the Biotech Industry to the Development of ... Will Hutton. 12. The State we are in: Designated and Approved OMPs in the EU and the US ...
jeopardizing this potential if we do not make. every attempt to reduce the cost of drug ... through tailor - made medicines. Allow for a better understanding ...
Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Read Complete Report @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Enquire @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market/enquire-about-report
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Get more details at: http://www.apacmarket.com/top-market/anti-inflammatory-therapeutics-market
Medical imaging is a technique used for the creating the visual representation of the internal body parts for the purpose of clinical analysis and medical intervention. The use of this technique revels internal structure that is hidden by the skin and bones for the diagnosis and treatment of disease. The medical imaging technique includes the use of several modern equipment such as CT scan, ultrasound, X-ray, MRI, and others. The market for medical imaging processing has witnessed a high growth due to increasing use of these techniques in the medical diagnosis, disease monitoring and treatment of disease. Read more at: https://www.alliedmarketresearch.com/medical-image-processing-market
Increasing prevalence of chronic diseases such as cancer will drive the Europe cell line development market. Cancer is one of the leading causes of morbidity and mortality in Europe. Extensive investment in R&D activities to reduce cancer burden in the region, will fuel need for cell line development for cancer treatment.
Big Market Research, Indian Coronary Stent Market Size, Share, Forecast, Trends, Growth, Demand, Analysis, Research, Report, Insights, Outlook to 2019.Heart diseases are on the rise in India. It is estimated that 10 percent of urban adult population and 5 percent of rural adult population suffer from some form of heart diseases and 20-30 percent of them require specialized investigation and treatment to prevent deaths due to heart ailments and coronary vascular diseases (CVD). market research report titled “Indian Coronary Stent Market Forecast to 2019”. The new research report revealed vivid and elaborate market information. For the decision makers of the coronary stents manufacturing companies this report, no doubt, will be a helpful tool to get the clear picture of the Indian market.
Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia. Symptoms include fatigue, pale skin, rapid or irregular heart rate, shortness of breath with exertion, nosebleeds and bleeding gums, prolonged bleeding from cuts, skin rash, dizziness and headache. Risk factors include exposure to toxic chemicals, treatment with high-dose radiation or chemotherapy for cancer, certain blood diseases, autoimmune disorders and serious infections. Treatment includes immunosuppressants and stem cell transplant. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/aplastic-anemia-pipeline-review-h1-2018/149565-91.html
The global biosimilars market size was valued at 3.39 billion in 2016 and is expected to grow on account of increasing prevalence of chronic diseases such as cancer and autoimmune disorders. Additionally, increasing prevalence of arthritic disorder and obesity across the globe in geriatric population is anticipated to drive the demand for biosimilar over the study period.